Clinical Trial Update: Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating allogeneic mesenchymal stem cells from umbilical cord for refractory systemic lupus erythematosus in Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• allogeneic mesenchymal stem cells derived from umbilical cord

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Lupus Erythematosus, Stem Cell Transplant | Phase 1, Phase 2 | Status: UNKNOWN